Bill > HB1337

This bill establishes the Therapeutic Psilocybin Working Group within the Department of Health to examine the medicinal and therapeutic effects of psilocybin or psilocybin-based products in treating mental health conditions, including post-traumatic stress disorder, depression, anxiety, and end-of-life psychological distress. The working group will also examine the effectiveness of medicinal and therapeutic uses of psilocybin in states that have legalized it, such as Oregon and Colorado, and develop a long-term strategic plan to ensure the safe availability and accessibility of affordable, therapeutic psilocybin or psilocybin-based products for adults 21 years of age or older. The working group will submit a report of its findings and recommendations, including any proposed legislation, to the legislature prior to the convening of the 2024 regular session.